The Role of Metformin and Colesevelam in Human GLP-1 Secretion
NCT02050074 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2014-10-07
Summary
Our primary hypothesis is that bile acid sequestrant colesevelam and the antidiabetic drug metformin potentiates the secretion of the gut hormone glucagon-like peptide 1 (GLP-1).
Conditions
Interventions
- DRUG
-
Colesevelam
- DRUG
- OTHER
-
Placebo
Sponsors & Collaborators
-
University Hospital, Gentofte, Copenhagen
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
Countries
- Denmark
Study Locations
More Related Trials
-
The Effect of GLP-1 on the Inhibition of Glucagon Secretion
NCT01507597 ·Status: COMPLETED ·Phase: NA
-
Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion
NCT02445508 ·Status: COMPLETED ·Phase: NA
-
The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus
NCT00145379 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Metabolic Complications of Glucocorticoid Excess
NCT01319994 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet
NCT00118937 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus
NCT00655603 ·Status: UNKNOWN ·Phase: NA
-
The Role of Pregnancy-induced Gallbladder Dysmotility in the Pathophysiology of Gestational Diabetes Mellitus
NCT04108065 ·Status: COMPLETED
-
Separate and Combined Extrapancreatic Effects of the Incretin Hormones
NCT05177653 ·Status: COMPLETED ·Phase: NA
-
Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects
NCT03682172 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans
NCT00876213 ·Status: COMPLETED
-
Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion
NCT01176708 ·Status: UNKNOWN ·Phase: NA
-
Metformin to Prevent Metabolic Complications in Glucocorticoid Excess
NCT01187849 ·Status: COMPLETED ·Phase: PHASE4
-
Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?
NCT03954873 ·Status: COMPLETED ·Phase: NA
-
The Influence of Cholecystectomy on Secretion of Incretin Hormones
NCT03305783 ·Status: COMPLETED
-
The Effect of Exogenous Glucagon-like Peptide 2 on Cholecystokinin-induced Gallbladder Emptying
NCT04651868 ·Status: COMPLETED ·Phase: NA
-
Hyperglycemia and the Extra-pancreatic Effect of Incretins
NCT01749163 ·Status: COMPLETED ·Phase: NA
-
Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176760 ·Status: UNKNOWN ·Phase: NA
-
GLP-1 Signaling in Truncally Vagotomized Subjects
NCT02940184 ·Status: UNKNOWN ·Phase: NA
-
Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment
NCT04177303 ·Status: UNKNOWN ·Phase: PHASE3
-
The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D
NCT03246451 ·Status: COMPLETED ·Phase: NA
-
The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)
NCT01449019 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes
NCT05297045 ·Status: TERMINATED ·Phase: PHASE2
-
Bile Acid-induced GLP-secretion. A Study in Cholecystectomized Subjects
NCT01251510 ·Status: COMPLETED
-
The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans
NCT00273000 ·Status: UNKNOWN ·Phase: NA
-
The Microvascular Function of GLP-1 and Its Analogues
NCT01677104 ·Status: COMPLETED ·Phase: NA